Law360, New York (March 10, 2009, 12:00 AM ET) -- Generic-drug maker Teva Pharmaceuticals USA Inc. has been slapped with a temporary restraining order barring it from launching a copycat version of Eli Lilly & Co.'s blockbuster osteoporosis drug Evista amid an ongoing patent litigation trial.
The 10-day restraining order was granted Monday in the U.S. District Court for the Southern District of Indiana, where a bench trial began Monday — the same day that a 30-month stay of the U.S. Food and Drug Administration's approval of Teva's application to manufacture a generic form of Evista...
Teva Hit With TRO Amid Lilly Evista Feud
To view the full article, take a free trial now.
